These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Digibind and free digoxin. Rainey P. Clin Chem; 1999 May; 45(5):719-21. PubMed ID: 10222369 [No Abstract] [Full Text] [Related]
8. [The monitoring of plasma digoxin levels during acute digitalis poisoning treated with Fab anti-digoxin fragments]. Milani L, Bizzaro N, Sanson A. G Ital Cardiol; 1992 Jan; 22(1):97-101. PubMed ID: 1624074 [Abstract] [Full Text] [Related]
10. Fab antibody fragments: some applications in clinical toxicology. Flanagan RJ, Jones AL. Drug Saf; 2004 Jan; 27(14):1115-33. PubMed ID: 15554746 [Abstract] [Full Text] [Related]
12. Influence of digoxin immune Fab therapy and renal dysfunction on the disposition of total and free digoxin. Ujhelyi MR, Robert S, Cummings DM, Colucci RD, Green PJ, Sailstad J, Vlasses PH, Zarowitz BJ. Ann Intern Med; 1993 Aug 15; 119(4):273-7. PubMed ID: 8328735 [Abstract] [Full Text] [Related]
17. [Antidigoxin Fab fragments and digoxin monitoring: a challenge for the biologist]. Parant F, Ducluzeau R, Lardet G, Gagnieu MC, Moulsma M. Ann Biol Clin (Paris); 2003 Aug 15; 61(6):645-53. PubMed ID: 14711605 [Abstract] [Full Text] [Related]
18. Digoxin assay anomalies due to digoxin-specific Fab immunotherapy. Natowicz M, Shaw L. DICP; 1991 Aug 15; 25(7-8):739-41. PubMed ID: 1949929 [Abstract] [Full Text] [Related]